# India Catheters Active Implantable CDMO Market > India Catheters Active Implantable CDMO Market Research Report By Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, Others) andBy End-Users (Medical Device OEM Companies, Academic and Research Institutes, Government Agencies) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 10.82% - **2024:** $ 374.5 Million - **2025:** $ 415.02 Million - **2035:** $ 1,159.7 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Smiths Medical (US), Cook Medical (US), ConvaTec Group (GB) **Report ID:** MRFR/MED/48374-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-catheters-active-implantable-cdmo-market-50131 --- ## Market Summary ## **India Catheters Active Implantable CDMO Market Overview** As per MRFR analysis, the India Catheters Active Implantable CDMO Market Size was estimated at 346.5 (USD Million) in 2023.The India Catheters Active Implantable CDMO Market Industry is expected to grow from 374.5(USD Million) in 2024 to 1,874 (USD Million) by 2035. The India Catheters Active Implantable CDMO Market CAGR (growth rate) is expected to be around 15.764% during the forecast period (2025 - 2035). ## **Key India Catheters Active Implantable CDMO Market Trends Highlighted** The India Catheters Active Implantable CDMO Market is growing due to multiple driving forces of the market, including an increase in chronic cardiovascular and other neurological diseases which increases the need for catheter-based treatments. Catheters are also on the rise due to medical technology innovations and a shift towards less invasive surgeries. Government efforts to improve healthcare systems and aid in the development of medical devices in India have also formed a good stance for the growth of this market. Programs such as Make In India support domestic manufacturing which in turn, promotes innovation and reduces the reliance on foreign imports. The rise of personal medicine and digital health offer countless opportunities for expansion in this market. The increase in telehealth and remote patient monitoring has made the development of smart catheters, capable of plugging into digital health systems for real-time observation, possible. Furthermore, increased focus on R&D spending by Indian CDMOs could foster the creation of next-generation catheters tailored for Indian patients with advanced safety and performance features. Recent trends show a movement towards using biocompatible materials and coatings, thereby improving patient care through reduced complications, in the manufacturing of catheters. Another important developmental focus is on catheters produced using green and sustainable materials and processes. This, along with the most recent rise in general health awareness among the Indian populace, drives greater demand for diagnostic and therapeutic catheters. In general, the India Catheters Active Implantable CDMO Market is responding to diverse trends in an adaptive and flexible manner to enable expansion within the healthcare market. ## **India Catheters Active Implantable CDMO Market Drivers** Increasing Prevalence of Cardiovascular Diseases In India, the rise in cardiovascular diseases has been marked as a significant driver for the India Catheters Active Implantable Contract Development and Manufacturing Organization Market. According to data from the Ministry of Health and Family Welfare, cardiovascular diseases are among the leading causes of death, contributing to about 27% of all deaths in India. This growing health crisis necessitates innovative solutions, including advanced catheter technologies. Established organizations like Medtronic and Boston Scientific are investing in the development of advanced catheter systems tailored for the Indian demographic. Their Research and Development efforts, along with localized manufacturing, are expected to address the increasing healthcare burden, ultimately supporting market growth in this sector. Government Initiatives for Healthcare Infrastructure The Indian government has been actively enhancing healthcare infrastructure, particularly through initiatives like the National Health Mission and the recent increase in budget allocation for healthcare. The government has allocated approximately USD 50.7 billion for health infrastructure in recent fiscal periods, aiming to improve access to quality healthcare. These initiatives are likely to accelerate the adoption of advanced medical devices such as catheters. As a result, companies like Abbott and Johnson & Johnson are ramping up their production capabilities in India, navigating local regulations to ensure better availability of active implantable devices. This push from the government and proactive industry response are vital growth factors for the India Catheters Active Implantable Contract Development and Manufacturing Organization Market. Technological Advancements in Medical Devices The continuous technological advancements in medical devices are fueling the growth of the India Catheters Active Implantable Contract Development and Manufacturing Organization Market. With features such as remote monitoring, miniaturization, and improved biocompatibility being developed, patients benefit from enhanced safety and efficacy. The Indian market is witnessing an influx of advanced technologically-driven products, supported by intellectual property filings that reported over 1,200 patents filed in the last three years for catheter technologies. Companies such as Stryker and Abbott Laboratories are at the forefront of these innovations, ensuring product relevance in a rapidly evolving healthcare market. Such advancements are crucial in catering to the diverse needs of the Indian populace, thereby expanding market opportunities. ## **India Catheters Active Implantable CDMO Market Segment Insights** ### **Catheters Active Implantable CDMO Market Service Category Insights** The India [Catheters Active Implantable CDMO](../../../reports/catheters-active-implantable-cdmo-market-26788) Market within the Service Category is an essential component of the country's healthcare ecosystem, contributing significantly to advancements in patient care and medical technology. This segment is primarily characterized by a variety of critical devices, including Catheters, Active Implantable Devices, and Endoscopy Devices, each playing a vital role in minimally invasive procedures and ongoing monitoring of medical conditions. Catheters are widely recognized for their versatility in a range of applications, including administering medications, collecting samples, and facilitating diagnostics, making them a cornerstone in medical settings.  The Active Implantable Devices segment encompasses a diverse array of technologies, such as pacemakers and implantable cardioverter defibrillators, which are pivotal in enhancing the quality of life for individuals suffering from chronic health conditions. Endoscopy Devices are also crucial within this segment, enabling physicians to perform diagnostic and therapeutic procedures with reduced recovery times due to their minimally invasive nature, thereby lessening the overall burden on healthcare systems. The growth of the India Catheters Active Implantable CDMO Market is driven by rising healthcare demands, increased investment in Research and Development, and a population that is becoming increasingly aware of health-related issues.  Government initiatives aimed at improving healthcare access and affordability, coupled with advancements in technology, have created a conducive environment for market players to thrive. However, challenges such as regulatory hurdles, the need for compliance with stringent quality standards, and the ongoing evolution of technologies present obstacles that companies must navigate carefully. Overall, the India Catheters Active Implantable CDMO Market is positioned for robust growth, with opportunities arising from technological advancements and increasing collaboration between manufacturers and healthcare providers concerning patient needs.  The segmentation of devices under the Service Category reflects a broader trend toward personalized healthcare and innovative solutions aimed at enhancing treatment outcomes, thereby ensuring a promising outlook for this segment in the foreseeable future. ### **Catheters Active Implantable CDMO Market End-Users Insights** The End-Users segment of the India Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market comprises crucial categories such as Medical Device Original Equipment Manufacturer (OEM) Companies, Academic and Research Institutes, and Government Agencies. Medical Device OEM Companies play a vital role as they are instrumental in the design and manufacture of innovative catheter technologies, driving advancements and improving patient outcomes. Their significant expertise demands high-quality, precise input from CDMO partners to meet regulatory standards and market requirements. Academic and Research Institutes contribute to the landscape through essential research and development activities. Their projects often focus on developing new applications and improving existing catheter designs, making them vital for pioneering innovations in the market. Meanwhile, Government Agencies are important players, providing essential regulatory guidance, funding for research initiatives, and support for public health programs, which aligns closely with the enhancement of healthcare infrastructure in India.  The collaboration among these End-Users fosters a dynamic environment, further strengthening the India Catheters Active Implantable CDMO Market, particularly as the Indian healthcare system continues to evolve and adapt to changing needs.With growing health concerns and investments in healthcare technology, the segment is positioned for significant growth in the coming years. **India Catheters Active Implantable CDMO Market Key Players and Competitive Insights:** The India Catheters Active Implantable CDMO Market has been witnessing a significant evolution, shaped by advancements in medical technology, increasing healthcare expenditure, and a growing patient population requiring specialized catheter solutions. In this competitive landscape, a myriad of contract development and manufacturing organizations (CDMOs) are striving to establish themselves, thereby creating an environment characterized by innovation, strategic partnerships, and investment in research and development.  The market is driven by the increasing prevalence of chronic diseases that necessitate the use of implantable catheters, prompting CDMOs to enhance their production capabilities while maintaining stringent regulatory compliance. Key players within the market are keen to leverage the rising demand for advanced catheter technologies and innovatively tailored products to gain a competitive edge, leading to an enriching ecosystem where both established firms and emerging players thrive concurrently.Stryker Corporation stands out as a formidable player within the India Catheters Active Implantable CDMO Market, exhibiting a strong presence characterized by a robust portfolio of advanced medical devices.  The company has developed a reputation for its cutting-edge technology and quality, which has allowed it to cater effectively to the unique demands of the Indian healthcare ecosystem. Stryker's expertise in the design and manufacturing of catheters places it in a favorable position, enabling streamlined operations and timely delivery of innovative solutions. Its commitment to excellence and efficacy in meeting regulatory standards has further solidified its credibility and trust among healthcare providers, allowing Stryker to actively engage with hospitals and clinics in India.  The company’s ability to leverage its global experience while adapting products and strategies to the local market dynamics enhances its competitive standing significantly.C.R. Bard also plays a vital role in the India Catheters Active Implantable CDMO Market, offering a comprehensive range of catheter solutions designed to address various clinical requirements. With a focus on innovation and quality, the company positions itself as a leading provider of medical technologies in India, catering primarily to hospitals and healthcare facilities. C.R. Bard's strengths lie in its well-established presence and reputation for delivering high-quality products that align with the specific needs and regulatory requirements of the Indian market.  The company emphasizes continuous improvements through research and development, leading to the introduction of new products that enhance patient care. Furthermore, C.R. Bard has engaged in strategic mergers and acquisitions to bolster its market presence in India, allowing it to expand its offerings and leverage synergies that support operational efficiencies. This proactive approach serves to reinforce C.R. Bard's competitive advantage in a rapidly evolving landscape of the catheter industry. **Key Companies in the India Catheters Active Implantable CDMO Market Include:** **India Catheters Active Implantable CDMO Market Industry Developments** Recent developments in the India Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market indicate significant competition and investment, driven by major players such as Stryker Corporation, C.R. Bard, Cook Medical, Terumo Corporation, B. Braun Melsungen, and Medtronic. The market is experiencing growth fueled by the rising prevalence of chronic diseases and an increasing emphasis on minimally invasive procedures. In terms of mergers and acquisitions, Medtronic announced its acquisition of Mazor Robotics in December 2018 to bolster its position in surgical robotics, affecting the catheter manufacturing landscape indirectly.  Additionally, Boston Scientific has been expanding its product portfolio through strategic collaborations to enhance its offerings in India. The market valuation for catheter-based devices has witnessed a surge from $560 million in 2020 to approximately $750 million in 2023, reflecting a compound annual growth rate of 13.5%. This growth is supported by initiatives from the Indian government aimed at boosting healthcare infrastructure and increasing domestic production of medical devices, thereby attracting investments from both national and international firms. Overall, India’s Catheters Active Implantable CDMO Market is poised for dynamic growth, responding to healthcare demands and innovations in technology. ## **India Catheters Active Implantable CDMO Market Segmentation Insights** ### **Catheters Active Implantable CDMO Market Service Category****Outlook** ### **Catheters Active Implantable CDMO Market End-Users****Outlook** ## Market Drivers ### Increasing Healthcare Expenditure The rise in healthcare expenditure in India is a pivotal driver for the catheters active-implantable-cdmo market. As the government and private sectors allocate more funds towards healthcare, the demand for advanced medical devices, including catheters, is likely to increase. In 2025, healthcare spending in India is projected to reach approximately $370 B, reflecting a growth rate of around 12% annually. This financial commitment facilitates the development and production of innovative catheter technologies, enhancing patient outcomes. Furthermore, the expansion of health insurance coverage is expected to improve access to these devices, thereby stimulating market growth. The catheters active-implantable-cdmo market stands to benefit significantly from this trend, as increased funding allows for better research, development, and distribution of catheter products. ### Government Initiatives and Policies Government initiatives and policies aimed at improving healthcare infrastructure are playing a significant role in shaping the catheters active-implantable-cdmo market. The Indian government has launched various programs to enhance medical device manufacturing and promote local production. Initiatives such as the 'Make in India' campaign are encouraging domestic companies to invest in the development of advanced medical technologies, including catheters. Additionally, regulatory frameworks are being streamlined to facilitate faster approvals for new devices, thereby accelerating market entry. These supportive policies are expected to bolster the catheters active-implantable-cdmo market, as they create a conducive environment for innovation and growth within the industry. ### Aging Population and Chronic Diseases India's demographic shift towards an aging population is a crucial factor influencing the catheters active-implantable-cdmo market. With an increasing number of elderly individuals, the prevalence of chronic diseases such as cardiovascular disorders and diabetes is also on the rise. By 2025, it is estimated that over 140 million people in India will be aged 60 and above, leading to a higher demand for medical interventions, including catheterization procedures. This demographic trend necessitates the production of specialized catheters that cater to the unique needs of older patients. Consequently, The catheters active-implantable CDMO market is likely to experience substantial growth. This growth is due to healthcare providers seeking to address the complexities associated with chronic conditions in the aging population. ### Rising Awareness of Health and Wellness There is a growing awareness of health and wellness among the Indian population, which is positively impacting the catheters active-implantable-cdmo market. As individuals become more health-conscious, there is an increased demand for preventive healthcare measures and timely medical interventions. This trend is leading to a higher acceptance of catheterization procedures, as patients seek effective solutions for managing their health conditions. Additionally, educational campaigns and initiatives by healthcare organizations are further promoting the benefits of early diagnosis and treatment. Consequently, the catheters active-implantable-cdmo market is likely to see an uptick in demand as more patients opt for catheter-based treatments, driven by their enhanced understanding of health management. ### Advancements in Manufacturing Technologies The catheters active-implantable-cdmo market is significantly influenced by advancements in manufacturing technologies. Innovations such as 3D printing and automation are revolutionizing the production processes of catheters, allowing for greater precision and customization. These technologies enable manufacturers to produce high-quality catheters at reduced costs, which is particularly beneficial in a price-sensitive market like India. Furthermore, the integration of smart technologies into catheter design is enhancing functionality and patient safety. As these manufacturing advancements continue to evolve, they are expected to drive the growth of the catheters active-implantable-cdmo market, making it more competitive and responsive to the needs of healthcare providers and patients alike. ## Future Outlook The [Catheters Active Implantable CDMO Market](https://www.marketresearchfuture.com/reports/catheters-active-implantable-cdmo-market-26788) is projected to grow at a 10.82% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of customized catheter solutions for niche medical applications. - Investment in advanced manufacturing technologies to enhance production efficiency. - Strategic partnerships with healthcare providers for integrated service offerings. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in innovative healthcare solutions. ## Segment Insights ### By Service Segment: Catheters (Largest) vs. Active Implantable Devices (Fastest-Growing) In the India catheters active-implantable-cdmo market, Catheters hold a substantial share, representing the largest segment due to their broad applications and widespread usage in medical procedures. Active Implantable Devices, while smaller in share, exhibit remarkable growth traits, driven by advancements in technology and rising demand for innovative medical solutions. Endoscopy Devices also play a key role, but currently, they lag behind Catheters and Active Implantable Devices in terms of share. The growth trends within this segment are fueled by several factors, including the increasing prevalence of chronic diseases, an aging population, and a heightened focus on minimally invasive surgeries. The drive for technological innovation is steering the market towards smarter, more efficient devices, benefiting both Catheters and Active Implantable Devices. Moreover, strategic partnerships and investments in research and development promise to further enhance the market's expansion, particularly for Active Implantable Devices, which are expected to capture more market share in the coming years. Catheters (Dominant) vs. Active Implantable Devices (Emerging) Catheters are the dominant player in the service segment, known for their versatility and essential role in various medical procedures, including surgery and diagnostics. They are characterized by a wide range of types and sizes, catering to different patient needs and medical applications, thus ensuring their substantial share of the market. Conversely, Active Implantable Devices are emerging, marked by their innovative technology and the ability to provide continuous monitoring and treatment solutions for patients. This segment is experiencing growth driven by advanced technology such as wireless communication and miniaturization, making them increasingly appealing to healthcare providers. Their integration into patient care is expected to enhance the overall treatment experience, gradually increasing their market presence and competitiveness. ### By End User: Medical Device OEM Companies (Largest) vs. Government Agencies (Fastest-Growing) The India catheters active-implantable-cdmo market exhibits a diverse market share distribution among its key end users. Medical Device OEM Companies dominate this segment, representing a significant portion of the overall market due to their established manufacturing capabilities and extensive distribution networks. In contrast, Government Agencies, while currently holding a smaller share, are rapidly expanding their influence in the market, driven by increased healthcare initiatives and public funding for advanced medical technologies. Growth trends in the India catheters active-implantable-cdmo market indicate a notable uptick in investments and collaborations among Academic and Research Institutes, Medical Device OEM Companies, and Government Agencies. The push towards innovation, coupled with the rising demand for advanced medical devices, positions Government Agencies as key players fostering growth. Furthermore, the increasing prevalence of chronic diseases necessitates better healthcare solutions, prompting these agencies to expand their reach in the market. Medical Device OEM Companies (Dominant) vs. Academic and Research Institutes (Emerging) Medical Device OEM Companies represent the dominant force in the India catheters active-implantable-cdmo market, leveraging their established expertise in manufacturing and strong relationships with healthcare providers. These companies focus on innovation and product development, enabling them to meet the growing demands of the healthcare sector effectively. On the other hand, Academic and Research Institutes are emerging as vital contributors to market growth, as they drive research and development initiatives that lead to advancements in catheter technologies. Their collaboration with OEMs facilitates knowledge exchange and accelerates the introduction of novel solutions to the market, thus enhancing the overall landscape of the India catheters active-implantable-cdmo market. ## Competitive Benchmarking The catheters active-implantable-cdmo market in India is characterized by a dynamic competitive landscape, driven by technological advancements and increasing healthcare demands. Major players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Medtronic (US) emphasizes its commitment to developing cutting-edge catheter technologies, while Boston Scientific (US) leverages its extensive research capabilities to introduce novel solutions. Abbott Laboratories (US) appears to be concentrating on expanding its product portfolio through acquisitions, thereby strengthening its competitive positioning in the market.The market structure is moderately fragmented, with several key players vying for dominance. Companies are increasingly localizing manufacturing to optimize supply chains and reduce costs. This tactic not only enhances operational efficiency but also allows for quicker response times to market demands. The collective influence of these major players shapes the competitive environment, as they continuously adapt to evolving consumer needs and regulatory requirements. In October Medtronic (US) announced the launch of a new line of advanced catheters designed for minimally invasive procedures. This strategic move is significant as it aligns with the growing trend towards less invasive surgical options, potentially increasing patient adoption rates and expanding Medtronic's market share. The introduction of these products is likely to enhance the company's reputation for innovation in the catheter space. In September Boston Scientific (US) entered into a partnership with a leading Indian healthcare provider to enhance its distribution network across the region. This collaboration is crucial as it not only broadens Boston Scientific's reach but also allows for better access to its advanced catheter technologies in underserved markets. Such strategic alliances are indicative of the company's focus on regional expansion and customer accessibility. In August Abbott Laboratories (US) completed the acquisition of a local catheter manufacturing firm, which is expected to bolster its production capabilities and streamline operations. This acquisition reflects Abbott's strategy to enhance its competitive edge by integrating local expertise and resources, thereby improving its supply chain efficiency and responsiveness to market changes. As of November the competitive trends in the catheters active-implantable-cdmo market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in navigating complex market dynamics. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, positioning companies to better meet the demands of a rapidly changing healthcare landscape. ## Recent News & Developments Recent developments in the India Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market indicate significant competition and investment, driven by major players such as Stryker Corporation, C.R. Bard, Cook Medical, Terumo Corporation, B. Braun Melsungen, and Medtronic. The market is experiencing growth fueled by the rising prevalence of chronic diseases and an increasing emphasis on minimally invasive procedures. In terms of mergers and acquisitions, Medtronic announced its acquisition of Mazor Robotics in December 2018 to bolster its position in surgical robotics, affecting the catheter manufacturing landscape indirectly.  Additionally, Boston Scientific has been expanding its product portfolio through strategic collaborations to enhance its offerings in India. The market valuation for catheter-based devices has witnessed a surge from $560 million in 2020 to approximately $750 million in 2023, reflecting a compound annual growth rate of 13.5%. This growth is supported by initiatives from the Indian government aimed at boosting healthcare infrastructure and increasing domestic production of medical devices, thereby attracting investments from both national and international firms. Overall, India’s Catheters Active Implantable CDMO Market is poised for dynamic growth, responding to healthcare demands and innovations in technology. ## Report Scope | MARKET SIZE 2024 | 374.5(USD Million) | | --- | --- | | MARKET SIZE 2025 | 415.02(USD Million) | | MARKET SIZE 2035 | 1159.7(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.82% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Smiths Medical (US), Cook Medical (US), ConvaTec Group (GB) | | Segments Covered | Service Segment, End User | | Key Market Opportunities | Advancements in biocompatible materials enhance innovation in the catheters active-implantable-cdmo market. | | Key Market Dynamics | Rising demand for innovative catheter solutions drives competition among active-implantable contract development and manufacturing organizations. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the projected market valuation for the India catheters active-implantable-cdmo market by 2035?** A: The projected market valuation for the India catheters active-implantable-cdmo market is $1159.7 Million by 2035. **Q: What was the market valuation for the India catheters active-implantable-cdmo market in 2024?** A: The market valuation for the India catheters active-implantable-cdmo market was $374.5 Million in 2024. **Q: What is the expected CAGR for the India catheters active-implantable-cdmo market during the forecast period 2025 - 2035?** A: The expected CAGR for the India catheters active-implantable-cdmo market during the forecast period 2025 - 2035 is 10.82%. **Q: Which companies are considered key players in the India catheters active-implantable-cdmo market?** A: Key players in the market include Medtronic, Boston Scientific, Abbott Laboratories, Johnson & Johnson, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical, Cook Medical, and ConvaTec Group. **Q: What are the segment valuations for catheters in the service segment?** A: The segment valuation for catheters in the service segment ranges from $100.0 Million to $300.0 Million. **Q: How do active implantable devices perform in the service segment?** A: Active implantable devices in the service segment have a valuation ranging from $150.0 Million to $450.0 Million. **Q: What is the valuation range for endoscopy devices in the service segment?** A: The valuation range for endoscopy devices in the service segment is from $124.5 Million to $409.7 Million. **Q: What is the market valuation for medical device OEM companies as an end user?** A: The market valuation for medical device OEM companies as an end user ranges from $149.8 Million to $455.0 Million. **Q: What is the valuation for government agencies as an end user in the market?** A: The valuation for government agencies as an end user is between $149.8 Million and $477.7 Million. **Q: What is the market valuation for academic and research institutes as an end user?** A: The market valuation for academic and research institutes as an end user ranges from $74.9 Million to $227.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-catheters-active-implantable-cdmo-market-50131*